Guardian Capital LP Bristol Myers Squibb CO Transaction History

Guardian Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $246,302 - $272,356	-5,520 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $269,155 - $349,029	5,520 New	5,520 $287,000
Q3 2017 Nov 15, 2017	SELL	$55.23 - $63.74 $273,333 - $315,449	-4,949 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	4,949	4,949 $276,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.